RESEARCH FRONTIERS INC
10-Q, EX-27, 2000-08-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: RESEARCH FRONTIERS INC, 10-Q, 2000-08-14
Next: JONES PHARMA INC, 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM FINANCIAL
STATEMENTS CONTAINED IN THE MOST RECENT QUARTERLY REPORT ON FORM
10-Q OF
RESEARCH FRONTIERS INCORPORATED FOR THE QUARTER ENDED JUNE 30,2000
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               JUN-30-2000
<CASH>                                      14,606,547
<SECURITIES>                                 3,292,686
<RECEIVABLES>                                  340,000
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            18,273,621
<PP&E>                                         318,131
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              18,614,357
<CURRENT-LIABILITIES>                        1,215,321
<BONDS>                                              0
                                0
                                          0
<COMMON>                                    12,134,571
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                18,614,357
<SALES>                                        198,734
<TOTAL-REVENUES>                               615,721
<CGS>                                                0
<TOTAL-COSTS>                                5,946,666
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                             (5,330,945)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (5,330,945)
<EPS-BASIC>                                     (.44)
<EPS-DILUTED>                                     (.44)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission